Abstract:Gallbladder cancer (GBC) is the most aggressive malignancy of the biliary tract cancer, and there is a lack of effective treatment. Here, we developed a nanoparticle platform (8P4 NP) that can deliver THZ1, a cyclin-dependent kinase 7 (CDK7) inhibitor, to treat GBC. Analysis of datasets demonstrated that CDK7 was positively correlated with poor prognosis. CDK7 inhibition suppressed cell proliferation, induced apoptosis, and caused cell cycle block in GBC cells. THZ1 downregulated CDK7-mediated phosphorylation of RNA polymerase II (RNAPII), resulting in a significant downregulation of transcriptional programs, with a preferential repression of oncogenic transcription factors. To improve the tumor targeting efficiency of THZ1, 8P4 NPs were prepared and assembled with THZ1 to form NPs. Compared with free THZ1, NPs showed more advantages in prolonging blood circulation, escaping from lysosomes and increasing cellular uptake. Importantly, NPs demonstrated a more significant inhibition effect on GBC cells than free THZ1 in vitro. In addition, 8P4 NPs could efficiently deliver THZ1 to tumor sites in a patient-derived xenograft model of early recurrence, leading to tumor regression and transcriptional inhibition with minimal toxicity. In summary, we conclude that NPs provide a potent therapeutic strategy that targets CDK7-mediated transcriptional addiction in GBC.The Supporting Information is available free of charge at https://pubs.acs.org/doi/10.1021/acsnano.1c04570.The synthetic route of 8-Phe-4 (8P4) polymer (Figure S1); correlation of CDK7 expression and T stage in human GBC (Figure S2); knockdown efficiency of CDK7 siRNA (Figure S3); representative flow cytometry data of apoptosis analysis of GBC cells after CDK7 inhibition (Figure S4); apoptosis analysis of GBC cells treated with siCONTROL+DMSO, siCDK7+DMSO, or siCONTROL+THZ1 for 48 h (Figure S5); the effects of CDK12/13 siRNAs on cell proliferation, apoptosis, and the cell cycle in GBC (Figure S6); the knockdown efficiency of JUN or FOSL1 siRNA (Figure S7); characterization of 8P4 polymer (Figure S8); cellular uptake behavior of NPs in GBC cells (Figure S9); the synthetic route of bio-THZ1 (Figure S10); characterization of bio-THZ1 (Figure S11); the cell-based assay of Bio-THZ1 (Figure S12); tumor targeting efficiency of NPs in vitro (Figure S13); the concentrations of serum alanine aminotransferase (ALT), creatinine (Cr), and blood urea nitrogen (BUN) in different treatment groups (Figure S14); sequences of siRNA and primers used for experiments in this study (Table S1) (PDF)This article has not yet been cited by other publications.

Inhibition of XPO1 with KPT-330 Induces Autophagy-Dependent Apoptosis in Gallbladder Cancer by Activating the P53/mtor Pathway

Inhibition of XPO1 impairs cholangiocarcinoma cell proliferation by triggering p53 intranuclear accumulation

Betulinic acid induces apoptosis of gallbladder cancer cells via repressing SCD1.

Cordycepin down-regulates multiple drug resistant (MDR)/HIF-1α through regulating AMPK/mTORC1 signaling in GBC-SD gallbladder cancer cells.

20(S)-Ginsenoside Rg3 Promotes Senescence And Apoptosis In Gallbladder Cancer Cells Via The P53 Pathway

XPO1 blockade with KPT-330 promotes apoptosis in cutaneous T-cell lymphoma by activating the p53–p21 and p27 pathways

Apkcι Promotes Gallbladder Cancer Tumorigenesis and Gemcitabine Resistance by Competing with Nrf2 for Binding to Keap1

Ciap1 Promotes Proliferation and Migration and Prevents Apoptosis in Gallbladder Cancer in Vitro

Effects of Platycodin D on Apoptosis, Migration, Invasion and Cell Cycle Arrest of Gallbladder Cancer Cells.

Knockdown of IGF2BP3 inhibits the tumorigenesis of gallbladder cancer and modifies tumor microenvironment

Modulation of mTOR and epigenetic pathways as therapeutics in gallbladder cancer

Analysis of the efficacy and prognostic factors of PD-1 inhibitors in advanced gallbladder cancer

Selinexor targeting XPO1 promotes PEG3 nuclear accumulation and suppresses cholangiocarcinoma progression

XPO1 inhibitor KPT-330 synergizes with Bcl-xL inhibitor to induce cancer cell apoptosis by perturbing rRNA processing and Mcl-1 protein synthesis

Inhibition of autophagy by chloroquine enhances the antitumor activity of gemcitabine for gallbladder cancer

Knockdown of SLC39A4 Expression Inhibits the Proliferation and Motility of Gallbladder Cancer Cells and Tumor Formation in Nude Mice

GDC-0980-induced Apoptosis is Enhanced by Autophagy Inhibition in Human Pancreatic Cancer Cells

The Role of PI3K/AKT Signaling Pathway in Gallbladder Carcinoma.

Nanomaterial-Facilitated Cyclin-Dependent Kinase 7 Inhibition Suppresses Gallbladder Cancer Progression via Targeting Transcriptional Addiction

Gallbladder Cancer Progression is Reversed by Nanomaterial-Induced Photothermal Therapy in Combination with Chemotherapy and Autophagy Inhibition.

Ponicidin inhibited gallbladder cancer proliferation and metastasis by decreasing MAGEB2 expression through FOXO4